Ignite Creation Date:
2024-05-06 @ 3:52 AM
Last Modification Date:
2024-10-26 @ 11:40 AM
Study NCT ID:
NCT02393599
Status:
COMPLETED
Last Update Posted:
2017-01-11
First Post:
2015-03-04
Brief Title:
Study to Assess Potential Interactions Between Intravenous Cocaine and Oral Lorcaserin
Sponsor:
National Institute on Drug Abuse NIDA
Organization:
National Institute on Drug Abuse NIDA
Study Overview
Official Title:
Phase 1 Double-Blind Placebo-Controlled Parallel-Group Study to Assess Potential Interactions Between Intravenous Cocaine and Oral Lorcaserin
Status:
COMPLETED
Status Verified Date:
2015-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The primary objective of this study is to determine if there are significant interactions between oral lorcaserin treatment concurrent with 20 and 40 mg intravenous iv cocaine infusions by measuring adverse events AEs and cardiovascular responses including heart rate HR blood pressure BP and electrocardiogram ECG including QTc
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None